Edition:
United States

Sino Biopharmaceutical Ltd (SBMFF.PK)

SBMFF.PK on OTC Markets Group

0.79USD
--
Change (% chg)

-- (--)
Prev Close
$0.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
73,799
52-wk High
$0.89
52-wk Low
$0.63

Summary

Name Age Since Current Position

Y Y Tse

23 2015 Executive Chairman of the Board

Ping Tse

64 2016 Chief Executive Officer, Executive Director

Cheung Ling Cheng

53 2017 Executive Vice Chairlady of the Board

Minggang Wang

59 2008 Vice Chairman of the Board and the General Manager of Qingdao Haier

Xinglong Zhuang

46 Assistant to the President and Secretary of the Board of CT Tianqing

Jinming Li

51 Vice President - CT Tianqing and Deputy General Manager - LYG Tianqing

Hsin Tse

46 Vice President, Executive Director

Mingqin Li

57 2015 Executive Director, Vice President

Fai Chia

2015 Assistant to the President and Vice President

Xiquan Zhang

46 2015 Vice President of R&D and Director of the CT Tianqing R&D Institute

Xiaoguang Shen

42 2015 Assistant to President and the General Manager of the investment management Department

Hsuan Tse

46 2008 General Manager - Information Management Department

Wei Nong Ye

53 Assistant President, General Manager - R&D Department

Yong Zhu

2015 General Manager of Jiangsu Qingjiang

Hong Wang

52 Deputy General Manager - LYG Tianqing

Kuanqi Wang

49 Deputy General Manager - NJCTT

Yangqing Zhang

47 Deputy General Manager of Finance Department of NJCTT

Zhenqian Zhang

46 Executive Deputy General Manager and Engineer - NJCTT

Chau Ling Yu

Assistant Vice President, Financial Controller

Zhoushan Tian

52 2015 Executive Director

Shanchun Wang

48 2015 Executive Director

Hui Cheng

52 Deputy Financial Controller

Chun Ling Li

44 Vice President - CTT

Zhaocheng Tang

49 Vice President - CT Tianqing

Wun Tse

2015 Assistant to the President

Junping Wang

2014 General Manager - Shanghai Tongyong

Xiangjian Wang

45 Vice President of CT Tianqing

Wenyu Xia

47 2014 General Manager and Director of Jiangsu Fenghai

Jie Zhang

45 Vice President - CTT

Oi Nin Chan

48 2015 Company Secretary

Dakui Li

72 2004 Independent Non-Executive Director

Hong Lu

47 2015 Independent Non-Executive Director

Zhengfei Lu

53 2005 Independent Non-Executive Director

Lu Fu Zhang

58 2015 Independent Non-Executive Director

Biographies

Name Description

Y Y Tse

Ms. Tse, Theresa Y Y is Executive Chairman of the Board of the Company since 30 June, 2015. Miss Tse is also a director of Golden Sword Ventures Limited. She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the investment, finance and business development departments of several companies.

Ping Tse

Mr. Tse Ping is Chief Executive Officer, Executive Director of the Company. He is the founder of the Company and now serves as an Executive Director of the Company. He is responsible for the overall operations of the Group. With more than 23 years of experience in investment and management in the pharmaceutical industry in the PRC, he is currently a director of CT Tianqing, NJCTT, Jiangsu Fenghai, Jiangsu Qingjiang, Qingdao Haier, Qingdao Chia Tai Haier Medicines Co., Ltd., Qingdao Heng Seng Tang Pharmacy Co., Ltd., and Beijing Tide. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd. and Chia Tai Oversea Chinese Realty Development Co., Ltd. He is also a non-executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”). Mr. Tse is still a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. (“CTQ”), a council member of the Association of Pharmaceutical Biotechnology of China and an honorary professor of Shenyang University of Pharmacy. Within the contemporary pharmaceutical industry, with the leadership by Mr. Tse, Sino Biopharmaceutical Limited has a leading position in the markets of hepatitis medicines and the therapeutic segment of micro-sphere target sustained medicine. CT Tianqing, Beijing Tide and CTQ were ranked the top 100 profit-making enterprises under the National Pharmaceutical Industrial Statistics Annual Report. In November, 2005, the Company was awarded one of the “Best under 1 US Billion enterprises within the Asian Pacific Region” by Forbes Asia. At the first “Capital – Chinese Outstanding Enterprise Achievement Prize” campaign launched by the Capital Magazine, the Company was awarded the “Capital – Chinese Outstanding Pharmaceutical Group Prize” in May, 2006.

Cheung Ling Cheng

Ms. Cheng Cheung Ling is an Executive Vice Chairlady of the Board of Sino Biopharmaceutical Ltd. She graduated from the Guanghua School of Management of Peking University and obtained a Master Degree in Business Administration. She is a clinician. Ms. Cheng has extensive experience in and a discerning vision for management and investment in the pharmaceutical industry. She spares no effort in promoting innovation and research and development capabilities in the industry. She is the chairman of Beijing Tide Pharmaceutical Co. Ltd. (“Beijing Tide”, an associate of the Group). As the Chairman of Beijing Tide, Ms. Cheng advocates for product innovation and uniqueness and has led Beijing Tide to focus on research and development innovations and international collaboration, to promote rapid development of cutting-edge technologies for medical products in China, and to give top priority to quality control, regarding product quality as the lifeblood of the company.

Minggang Wang

Mr. Wang Minggang is the Vice Chairman of the Board and the General Manager of Qingdao Haier of Sino Biopharmaceutical Ltd. He joined the Group in September, 2008 and is the vice chairman of the board of directors and the general manager of Qingdao Haier. He is also a practicing doctor and a senior engineer. Mr. Wang had worked in some large-scale domestic and foreign pharmaceutical companies and he has more than 26 years of experience in the pharmaceutical industry. He was the sales director of Xian CP. Mr. Wang is a council member of Qingdao Pharmaceutical Association, a council member of Qingdao Medical Association, the chairman of Qingdao Pharmaceutical Profession Association as well as a member of the 14th Qingdao Laoshan District’s Committee of the Chinese People’s Political Consultative Conference and a Qingdao deputy to the 15th National People’s Congress.

Xinglong Zhuang

Mr. Zhuang Xinglong is Assistant to the President and Secretary of the Board of CT Tianqing of the Company. He graduated from Heilongjiang University of Chinese Medicine and holds a Bachelor degree in Chinese medicine. Mr. Zhuang joined the Group in January, 2008 and is currently the secretary of the board of CT Tianqing.

Jinming Li

Mr. Li Jinming is Vice President - CT Tianqing and Deputy General Manager - LYG Tianqing of Sino Biopharmaceutical Ltd. He studied pharmaceutical major at Chinese Pharmaceutical University, and holds an MBA degree awarded by Sun Yatsen University. Mr. Li had worked as major district manager and deputy general manager in two well-known pharmaceutical enterprises in the PRC. Mr. Li has extensive sales and team management experience.

Hsin Tse

Mr. Tse Hsin is an Executive Director, Vice President of Sino Biopharmaceutical Ltd. He is mainly responsible for the acquisition and merger activities of the Group. He is also the Group’s spokesman. Mr. Tse Hsin graduated from the University of Hong Kong with a Bachelor’s Degree (Honors) in Industrial Engineering. He joined the Group in August, 1995 as an assistant to the president of the Company and served as the general manager of Xian C.P. Pharmaceutical Co., Ltd. (“Xian CP”). Mr. Tse Hsin is a council member of the first council and the executive council member of the second council of Chaozhou Natives Chamber of Commerce Beijing. He is also an executive member of the Right Protection Association for the Medical Treatment Equipment Enterprises of the Shaanxi Province, the vice chairman of the fourth council of the Foreign Invested Enterprises Association of the Shaanxi Province, the executive member of the third committee of the Shaanxi Cancer Fighting Association and the vice chairman of the World Chinese Medicine and Pharmaceutical Professional Joint Committee. He was also awarded the “Outstanding Management Award for Foreign-invested Enterprises of Shaanxi Province” and “Outstanding Entrepreneur who cares about his staff” by the Shaanxi Provincial Government. He was an executive director of Beijing Tide. He is currently a director of CT Tianqing, Qingdao Haier and Chia Tai Shaoyang Orthopedic Hospital.

Mingqin Li

Ms. Li Mingqin is Executive Director, Vice President of Sino Biopharmaceutical Ltd. She is currently the vice president of the Company and a director of Beijing Tide, Chia Tai Shaoyang Orthopedic Hospital and CP Boai Investment Ltd., and is principally responsible for the investment affairs of the Group. Ms. Li graduated from the Faculty of Medicine of Beijing Chinese Medicine University with a Bachelor Degree in medicine. Prior to joining the Company, Ms. Li had worked in Sino-Japanese Friendly Hospital and Beijing Chinese Medicine University, engaged in the teaching of medicines, development of new medicines and medicine management. During the period from 1992 to 1995, Ms. Li had been engaged in post-doctorate research in the Medicine School of University of Colorado, USA and the Medical College of the University of Massachusetts. Ms. Li joined the Group in March, 1997 and has 33 years of experience in the pharmaceutical industry.

Fai Chia

Ms. Chia Fai is Assistant to the President and Vice President of Sino Biopharmaceutical Ltd. She joined the Group in November, 1991 and has more than 26 years of experience in financial areas. Ms. Chia is a director of various companies including Chia Tai Medicines Investment Limited, Chia Tai Pharmaceutical (Lianyungang) Company Limited, Chia Tai Refined Chemical Industry Limited, Evon Industries Limited, Talent Forward Limited, Sino Biopharmaceutical (Beijing) Limited and Magnificent Technology Limited.

Xiquan Zhang

Mr. Zhang Xiquan is Vice President of R&D and Director of the CT Tianqing R&D Institute of Sino Biopharmaceutical Ltd. He graduated from the chemistry department of Nankai University with a Master of Science degree in 1994. He has carried out a number of studies of new drugs with expertise in drug candidate selection and drug development with partners. Mr. Zhang joined CT Tianqing in April, 1997.

Xiaoguang Shen

Mr. Shen Xiaoguang is Assistant to President and the General Manager of the investment management Department of Sino Biopharmaceutical Ltd. He participates in the business development and management of the Group, and is responsible for the market analysis of major products and R&D of new products. Mr. Shen graduated from the Heilongjiang College of Business with a Bachelor degree in pharmaceutical manufacturing, and has 18 years of experience in pharmaceutical sales and product R&D. Mr. Shen joined the Group in February, 2003.

Hsuan Tse

Mr. Tse Hsuan (Johnny) is General Manager - Information Management Department of Sino Biopharmaceutical Ltd. He joined the Group in January, 2003, and is principally responsible for the development and maintenance of the information system of the Company. Mr. Tse graduated from the University of Oregon with a Bachelor degree in computer science in the United States. He also studied at ESMOD (Ecole International de Mode Paris) in Paris of France with a diploma in fashion design and pattern drafting. Before joining the Company, Mr. Tse worked in Beijing Major Kind Co., Ltd. as a designer and a manager of information department. His design of uniform for air attendants was adopted by Air China.

Wei Nong Ye

Dr. Ye Wei Nong, Ph.D., is Assistant President, General Manager - R&D Department, subsidiary of Sino Biopharmaceutical Ltd. He is responsible for biotechnology development of the Group. He is currently a director of China Biotech & Drug Development Limited and Jiangsu Fenghai. In 1983, Dr. Ye graduated from Sun Yat-sen University with a Bachelor degree in biochemistry. In 1989, Dr. Ye obtained a doctoral degree in microbiology from the Institut National des Sciences Appliquees (INSA) de Toulouse of France. He also obtained a certificate of study for the post-graduate MBA programme of food technology and marketing from Ecole Superieure de Commerce (ESC) de Toulouse of France. Prior to joining the Group in July, 2002, he worked in Europe and Hong Kong for biotechnology and pharmaceutical companies. Dr. Ye was a member of the Advisory Committee on Applied Biology and Chemical Technology of The Hong Kong Polytechnic University from February, 2006 to September, 2014. He is a council member of the 8th Subcommittee of Industrial Biochemistry and Molecular Biology under the Chinese Society of Biochemistry and Molecular Biology.

Yong Zhu

Mr. Zhu Yong is General Manager of Jiangsu Qingjiang of the Company since 2005, He has been the marketing director of Jiangsu Fenghai since 2005, and is mainly responsible for the marketing and academic promotion of new products, establishing the brand name of Fenghai and formulating successful marketing strategies for leading and developing market which resulted in the widespread recognition of the image of “New Model of Sugar Infusion Solution” of Jiangsu Fenghai by the pharmaceutical industry. In 2008, as a sales vice president, he initiated Jiangsu Fenghai’s characteristic mixed marketing model with success. In 2011, he was the executive vice president of Jiangsu Fenghai, responsible for R&D, marketing and human resources, and set up a medical R&D centre in Nanjing and established the training system for all levels of staff. In October, 2014, he served as executive vice president of Jiangsu Qingjiang and was responsible for R&D, human resources and office administration. From January, 2015 onwards, he is the general manager of Jiangsu Qingjiang and is responsible for overall management of Jiangsu Qingjiang.

Hong Wang

Mr. Wang Hong is Deputy General Manager - LYG Tianqing of the Company. He is responsible for sales management. Mr. Wang graduated from Shanghai Medical University with a Master degree in medical science in 1991, and also holds an MBA degree from the Business School of the National University of Singapore. He was the Derm Franchise Sales Manager of Xian- Janssen Pharmaceutical Ltd., where he had worked for 8 years. Mr. Wang has more than 18 years of experience in sales. He joined the Group in December, 2002, and was a director of marketing and a deputy general manager.

Kuanqi Wang

Mr. Wang Kuanqi is Deputy General Manager - NJCTT of Sino Biopharmaceutical Ltd. He is responsible for production. Mr. Wang graduated from Changzhou Chemical Institute with the profession qualification in organic synthesis. He joined CT Tianqing in 1988. He studied pharmacy at China Pharmaceutical University from 1999 to 2002. He was a team leader and an officer of production lines, a production manager and an assistant to general manager.

Yangqing Zhang

Mr. Zhang Yangqing is Deputy General Manager of Finance Department of NJCTT of the Company. He was graduated from the engineering management faculty of Central South University with a Bachelor degree in industrial engineering management in 1990. He is a certified accountant and a practicing registered real estate appraiser. He was a member of National Development and Reform Commission of Ziyang District of Yiyang City in Hunan Province, a civil servant of Housing Administrative Bureau of Yiyang City, an audit manager of Hunan Kaiyuan CPA, a financial controller of Chengdu Jiuzhitang Jinding Pharmaceutical Ltd., a deputy head of finance department and a director of marketing centre of Jiuzhitang Co., Ltd., the head of audit department of CT Tiangqing, a finance manager of the Group, and a deputy general manager of finance department of Jiangsu Fenghai.

Zhenqian Zhang

Mr. Zhang Zhenqian is Executive Deputy General Manager and Engineer - NJCTT of the Company. He joined the Group in April, 1997 and is responsible for the sales and operations of NJCTT. Graduated from Xuzhou College of Engineering, Mr. Zhang has completed the studies in EMBA program of Guanghua Management School of Peking University. Mr. Zhang has over 19 years of experience in pharmaceutical industry and was a branch manager and a major district manager of CT Tianqing.

Chau Ling Yu

Ms. Yu Chau Ling, CPA, FCCA, is Assistant Vice President, Financial Controller of Sino Biopharmaceutical Ltd. She graduated from the University of Hong Kong with a Bachelor degree in social sciences and in 2005 obtained an MBA Degree from The Open University of Hong Kong. She is the fellow member and an associate member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants, respectively. Ms. Yu joined the Company in February, 2003 and has extensive working experience in international audit firm and listed companies.

Zhoushan Tian

Mr. Tian Zhoushan is an Executive Director of the Company. He joined the Group in April, 1997 and is responsible for the business of NJCTT. Mr. Tian is the vice president of Lianyungang Chia Tai Tianqing Medicines Co., Ltd. (“LYG Tianqing”) and the general manager of NJCTT. Mr. Tian completed MBA coursework in Nanjing University. He was the head of production and the assistant to the president of CT Tianqing, and has 27 years of experience in the pharmaceutical industry.

Shanchun Wang

Mr. Wang Shanchun is Executive Director of Sino Biopharmaceutical Ltd. He is the president of CT Tianqing. He graduated from Nanjing University of Chemistry in July, 1990 and joined CT Tianqing in the same year. Mr. Wang studied a Master Degree in pharmaceutical engineering with Tianjin University from 1999 to 2002. He had been a vice officer and an officer of the production plant, the deputy head and the head of the engineering department, the director of GMP office, the vice general engineer, the general engineer and the executive vice president. Mr. Wang has rich management experience in the PRC pharmaceutical field. His design of the new production plant in CT Tianqing Haizhou obtained the first new edition national GMP certificate. He was awarded as a Lianyungang City Technology Advanced Worker, a Jiangsu Province Technology Advanced Worker and a Jiangsu Province Model Labour and the Jiangsu Province Science Technology Second Honour Award.

Hui Cheng

Ms. Cheng Hui is Deputy Financial Controller of Sino Biopharmaceutical Ltd. She joined the Group in May, 1993 and is responsible for the Group’s PRC financial and personnel issues. She was the head of the finance department in China Construction Bank (Zaozhuang City Branch). Ms. Cheng has 25 years of working experience in finance and accounting. She was awarded the accountancy qualification certificate issued by Ministry of Finance and Ministry of State Personnel, and ACCA Chinese finance and accounting qualification certificate issued by the Association of Chartered Certified Accountants. Ms. Cheng received international advanced human resources management professional training held by the International Public Management Association for Human Resources (IPMA-HR) and advanced training for PRC financial investment held by the School of Economics of Peking University.s

Chun Ling Li

Ms. Li Chun Ling is Vice President of CTT, subsidiary of Sino Biopharmaceutical Ltd. She is responsible for the financial and accounting affairs of CT Tianqing. Ms. Li joined the Group in February, 1996, worked in the audit department and finance and accounting departments of the Group, and was an accounting manager of the Group. Ms. Li graduated from Guizhou College of Finance and Accounting. She had worked in audit firms and served as a team in-charge for social auditing of projects. Ms. Li has over 17 years experience in finance and accounting, and is a certified accountant in the PRC.

Zhaocheng Tang

Mr. Tang Zhaocheng is Vice President - CT Tianqing of Sino Biopharmaceutical Ltd. He is responsible for the production management of CT Tianqing, and the general manager of LYG Runzhong. Mr. Tang joined CT Tianqing in April, 1997. He has a professional qualification in chemical engineering. Mr. Tang was a deputy director of production technology department, and manager of quality control as well as a chief officer of GMP and assistant to president of CT Tianqing. He was a team leader in the production of Ganlixin and Zegui Longshuang in CT Tianqing. Mr. Tang has over 22 years of experience in the pharmaceutical industry.

Wun Tse

Ms. Tse Wun is Assistant to the President of Sino Biopharmaceutical Ltd. She joined the Group in November, 1991. She is principally responsible for administration and financial matters of the Group’s office in Hong Kong. Ms. Tse graduated from the University of Oregon with a Bachelor of Science degree. She was formerly a director of Shenzhen 999 Pharmaceutical Co., Ltd. and has more than 20 years of experience in finance and investment.

Junping Wang

Mr. Wang Junping is General Manager - Shanghai Tongyong of the Company. He obtained a Bachelor degree from the Material Science and Chemical Application faculty of National University of Defense Technology in 1989, and obtained an MBA degree from Tinajin University Management College in 2000. He studied industrial property rights management at the Japan Association for Overseas Technical Scholarship. He has 26 years of experience in the pharmaceutical industry. He was the senior management of North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. and Fu Ren Medicines Group and was responsible for the management of R&D, technology, policy and sales.

Xiangjian Wang

Mr. Wang Xiangjian is Vice President of CT Tianqing of the company. He graduated from Nankai University and holds a Bachelor degree in molecular biology. Mr. Wang joined the Group in June, 1994 and is responsible for clinical monitoring and new medicine registration of CT Tianqing R&D Institute.

Wenyu Xia

Mr. Xia Wenyu is the General Manager and Director of Jiangsu Fenghai of the company. He has a professional qualification in finance and accounting discipline with tertiary education level and is an accountant. He graduated from the post-graduate MBA programme of the Renmin University of China. He has been a general manager and director of Jiangsu Fenghai since September, 2014 and previously served as the head of finance department, deputy head of corporate restructuring committee, manager of financial planning department, board secretary, assistant to general manager and manager of logistic department, sales director and deputy general manager of Jiangsu Fenghai. He has ample experience in corporate management, marketing, human resources and financial management and has 29 years of experience in the pharmaceutical industry. He is a standing council member of the China Price Association and Jiangsu Province Medical Insurance Committee.

Jie Zhang

Mr. Zhang Jie is Vice President - CTT. He graduated from Henan University and holds an MBA degree. Mr. Zhang joined the Group in July, 1993 and is responsible for the office affairs of CT Tianqing.

Oi Nin Chan

Mr. Chan Oi Nin Derek is Company Secretary of the Company since August, 2015. Mr. Chan has nearly 20 years of experience in accounting and auditing and, before joining the Company, was the company secretary of another company listed on the Stock Exchange. He is a fellow member of the Association of Chartered Certified Accountants and an associate member of the Hong Kong Institute of Certified Public Accountants. Mr. Chan received a Bachelor of Science degree from the Chinese University of Hong Kong in 1989 and an MBA degree from Monash University in 1995.

Dakui Li

Mr. Li Dakui is an Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He joined the Company as an independent non-executive director and a member of the Audit Committee of the Company in September, 2004. He graduated from the Faculty of Pharmacy of Beijing Medical University (now known as the School of Pharmaceutical Sciences of Beijing University) in 1965, and obtained a Master Degree in Pharmaceutics from Peking Union Medical College (“PUMC”) in 1982. He used to be the chief pharmacist of PUMC Hospital (retired in 2013) and the director of Pharmacy Department of PUMC Hospital for years. Mr. Li was a vice president of the Chinese Pharmaceutical Association, the Chairman of the Committee of Hospital Pharmacy Branch of Chinese Pharmaceutical Association and the vice chairman of the Chinese Practicing Pharmacist Association. He is currently a vice editor of the Chinese Pharmaceutical Magazine, and a member of the Chinese Pharmaceutical Committee and the vice team leader of its medicine professional team.

Hong Lu

Ms. Lu Hong is an Independent Non-Executive Director of the Company. She joined the Company as an independent non-executive director and a member of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company in April, 2015. Ms. Lu has over 20 years of experience in accounting, financial management, company secretary and domestic and overseas capital operations fields. She is a member of the Chinese Institute of Certified Public Accountants and the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. Ms. Lu has extensive knowledge of PRC and international accounting standards and the listing rules and regulations of both Hong Kong and PRC. She has been in charge of or involved in the entire process of the listing of multiple corporations in the PRC, Hong Kong, Singapore and the United States of America and quite a number of foreign and domestic investment and financing operations as well as mergers and acquisitions. She is familiar with financial analysis, budgeting, financial management and tax planning. She also has expertise in dealing with complex financing and taxation matters.

Zhengfei Lu

Mr. Lu Zhengfei is an Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He is the Chairman of the Audit Committee and a member of the Remuneration Committee and the Nomination Committee of the Company. He received a P.h.D. Degree in Economics (financial management). Mr. Lu is currently a Distinguished Professor of Chang Jiang Scholars and supervisor of doctoral students of the Guanghua School of Management of Peking University. He had previously held various senior positions in the Department of Accounting of both Peking University and Nanjing University. He is an expert consultant of the China Financial Accounting Standards Board, Ministry of Finance. He is also a standing council member of the China Accounting Association and the deputy director of its Financial Management Committee. Mr. Lu is the editor of several accounting and finance journals and has issued various publications. He is an independent non-executive director of Bank of China Limited, China National Materials Company Limited and Sinotrans Limited and an independent supervisor of PICC Property and Casualty Company Limited, shares of all four companies being listed on the Stock Exchange.

Lu Fu Zhang

Mr. Zhang Lu Fu is Independent Non-Executive Director of the Company. He joined the Company as an independent non-executive director and the chairman of the Remuneration Committee and a member of the Nomination Committee of the Company in April, 2015. Mr. Zhang holds a Master Degree in Philosophy from the Beijing Normal University, and is currently a research associate and a part-time professor. Mr. Zhang has been working for multiple sectors of the Chinese government since 1987, including the Hong Kong branch of the Xin Hua News Agency (Liaison Office of the Central People’s Government in Hong Kong). Mr. Zhang has worked for a number of Hong Kong listed companies and charitable organisations on full-time and part-time basis. Mr. Zhang is a council member of the China Overseas Friendship Association, a standing council member of the Guangdong Overseas Friendship Association, a council member of the Shenzhen Overseas Friendship Association, a member of the Shenzhen Committee of the 4th Chinese People’s Political Consultative Conference, and a part-time professor of the Hong Kong Academy of Management and the Hong Kong Financial Services Institute. Mr. Zhang is an independent non-executive director of Kingboard Laminates Holdings Limited which is listed on the Stock Exchange.